Re: Daniel M. Geynisman. Anti-programmed cell death protein 1 (PD-1) antibody nivolumab leads to a dramatic and rapid response in papillary renal cell carcinoma with sarcomatoid and rhabdoid features. Eur Urol 2015;68:912–4
ISSN
03022838
Date Issued
2017
Author(s)
DOI
10.1016/j.eururo.2016.06.039